NEWS & EVENTS
Researchers funded by the National Institute of Biomedical Imaging and Bioengineering have demonstrated that their novel Tongue Drive System is superior to other assistive devices used by individuals with tetraplegia.
NIBIB grantee Quyen Nguyen was named one of 102 recipients of the Presidential Early Career Awards for Scientists and Engineers, the highest honor bestowed by the U.S. government on early stage science and engineering professionals in recognition of their innovative research and commitment to community service. Read the full press release at whitehouse.gov.
An NIBIB-funded biomedical engineer at Vanderbilt University has constructed a sponge-like, biodegradable tissue “scaffold” that releases an enzyme-blocking molecule to indirectly activate endogenous pathways and enhance tissue regeneration and wound healing. Read the full release at news.vanderbilt.edu.
Dr. Robert Langer of MIT, currently funded by NIBIB and several other NIH Institutes, was one of six recipients of a 2014 Breakthrough Prize in Life Science from the Breakthrough Prizes in Life Sciences Foundation, a relatively new philanthropic organization that awards $3 million prizes to outstanding scientists in support of forward-thinking research and the pursuit of bold projects. Read the full press release at breakthroughprizeinlifesciences.org.
NIBIB program director Antonio Sastre discusses the work of grantee Yuni Dewaraja on refining radiation dosimetry in radioimmunotherapy for non-Hodgkin lymphoma and possible implications for changing the standard of care. Read the full article at healthcare-executive-insight.advanceweb.com.
Boston University profiles NIBIB grantee Chris Chen and his work in regenerative medicine. Read the full article at bu.edu.
Nanoparticles hold promise for delivering drugs to specific targets in the body, but oral delivery remains out of reach because nanoparticles can't penetrate the lining of the intestinal tract. Researchers at the MIT and Brigham and Women's Hospital have recently developed a way for nanoparticles to break through the intestinal lining of mice, possibly paving the way for their use in oral medications. Read the full story at WSJ.com